Phenotypic alteration of neuropeptide-containing nerve fibres in seasonal intermittent allergic rhinitis

Clinical and Experimental Allergy

Volumn 34, Issue 7, 2004, Pages 1105-1110

  Heppt, W ^a   Thai Dinh, Q ^b,c   Cryer, A ^a   Zweng, M ^c   Noga, O ^b   Peiser, C ^b   Melvan, M ^b   Witt, C ^b   Fischer, A ^b   Groneberg, D A ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Allergy; Human; Mucosa; Nasal; Neuropeptides; Rhinitis; Seasonal

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NEUROPEPTIDE; NEUROPEPTIDE Y; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; BIOPSY; CELL COUNT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MAST CELL; NERVE FIBER; NOSE MUCOSA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

BIOPSY; CALCITONIN GENE-RELATED PEPTIDE; CASE-CONTROL STUDIES; EOSINOPHILS; HUMANS; IMMUNOHISTOCHEMISTRY; MAST CELLS; NASAL MUCOSA; NERVE FIBERS; NEUROPEPTIDE Y; NEUROPEPTIDES; RHINITIS, ALLERGIC, SEASONAL; SUBSTANCE P; VASOACTIVE INTESTINAL PEPTIDE;

EID: 3242758924     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.01990.x     Document Type: Conference Paper

References (49)

1. Sibbald B. Epidemiology of allergic rhinitis. Monogr Allergy 1993; 31:61-79.
2. Fadal RG. IgE-mediated hypersensitivity reactions. Otolaryngol Head Neck Surg 1993; 109:565-78.
3. Pipkorn U, Karlsson G, Enerback L. Secretory activity of nasal mucosal mast cells and histamine release in hay fever. Int Arch Allergy Appl Immunol 1988; 87:349-60.
4. Krayenbuhl MC, Hudspith BN, Brostoff J et al. Nasal histamine release following hyperosmolar and allergen challenge. Allergy 1989; 44:25-9.
5. White MV, Kaliner MA. Mediators of allergic rhinitis. J Allergy Clin Immunol 1992; 90:699-704.
6. Raphael GD, Meredith SD, Baraniuk JN et al. The pathophysiology of rhinitis. II. Assessment of the sources of protein in histamine-induced nasal secretions [see comments]. Am Rev Respir Dis 1989; 139:791-800.
7. Pipkorn U. Mediators and nasal allergy. Clin Exp Allergy 1989; 19:585-9.
8. Naclerio RM, Baroody FM, Togias AG. The role of leukotrienes in allergic rhinitis: a review. Am Rev Respir Dis 1991; 143:891-5.
9. Schwartz LB. Mediators of human mast cells and human mast cell subsets. Ann Allergy 1987; 58:226-35.
10. Durham SR, Ying S, Varney VA et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148:2390-4.
11. Mosimann BL, White MV, Hohman RJ et al. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol 1993; 92:95-104.
12. Baraniuk JN, Kaliner M. Neuropeptides and nasal secretion. Am J Physiol 1991; 261:223-35.
13. Groneberg DA, Springer J, Fischer A. Vasoactive intestinal polypeptide as mediator of asthma. Pulm Pharmacol Ther 2001; 14:391-401.
14. Fischer A, Folkerts G, Geppetti P, Groneberg DA. Mediators of asthma: nitric oxide. Pulm Pharmacol Ther 2002; 15:73-81.
15. Groneberg DA, Fischer A. Endogenous opioids as mediators of asthma. Pulm Pharmacol Ther 2001; 14:383-9.
16. Fischer TC, Hartmann P, Loser C et al. Abundant expression of vasoactive intestinal polypeptide receptor VPAC2 mRNA in human skin. J Invest Dermatol 2001; 117:754-6.
17. Zamboni M. Buffered picric acid-formaldehyde: a new, rapid fixative for electron microscopy. J Cell Biol 1967; 35:148A.
18. Groneberg DA, Hartmann P, Dinh QT, Fischer A. Expression and distribution of vasoactive intestinal polypeptide receptor VPAC(2) mRNA in human airways. Lab Invest 2001; 81:749-55.
19. Groneberg DA, Nickolaus M, Springer J et al. Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake. Am J Pathol 2001; 158:707-14.
20. Groneberg DA, Doring F, Eynott PR, Fischer A, Daniel H. Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1. Am J Physiol Gastrointest Liver Physiol 2001; 281:0697-704.
21. Hacker GW, Kronberger C, Albegger K et al. Regulatory peptides and general neuroendocrine markers in human nasal mucosa - an immunocytochemical study. Wien Med Wochenschr 1989; 104 (Suppl.):71-3.
22. Figueroa JM, Mansilla E, Suburo AM. Innervation of nasal turbinate blood vessels in rhinitic and nonrhinitic children. Am J Respir Crit Care Med 1998; 157:1959-66.
23. Heppt W, Peiser C, Cryer A et al. Innervation of human nasal mucosa in environmentally triggered hyperreflectoric rhinitis. J Occup Environ Med 2002; 44:924-9.
24. Groneberg DA, Heppt W, Cryer A et al. Toxic rhinitis-induced changes of human nasal mucosa innervation. Toxicol Pathol 2003; 31:326-31.
25. Baraniuk JN, Lundgren JD, Goff J et al. Calcitonin gene-related peptide in human nasal mucosa. Am J Physiol 1990; 258:L81-8.
26. Baraniuk JN, Lundgren JD, Okayama M et al. Substance P and neurokinin A in human nasal mucosa. Am J Respir Cell Mol Biol 1991; 4:228-36.
27. Hua XY. Tachykinins and calcitonin gene-related peptide in relation to peripheral functions of capsaicin-sensitive sensory neurons. Acta Physiol Scand 1986; 551 (Suppl.):1-45.
28. Lundblad L. Protective reflexes and vascular effects in the nasal mucosa elicited by activation of capsaicin-sensitive substance P-immunoreactive trigeminal neurons. Acta Physiol Scand 1984; 529 (Suppl.):1-42.
29. Stjarne P, Lundblad L, Lundberg JM, Anggard A. Capsaicin and nicotine-sensitive afferent neurones and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br J Pharmacol 1989; 96:693-701.
30. Saria A, Martling CR, Yan Z et al. Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am Rev Respir Dis 1988; 137:1330-5.
31. Barnes PJ. Neuropeptides in human airways: function and clinical implications. Am Rev Respir Dis 1987; 136:877-83.
32. Albegger K, Hauser-Kronberger CE, Saria A et al. Regulatory peptides and general neuroendocrine markers in human nasal mucosa, soft palate and larynx. Acta Otolaryngol 1991; 111:373-8.
33. Anggard A. Basic mechanisms in autonomic nervous responses in specific and nonspecific nasal hyperreactivity. Acta Otolaryngol 1993; 113:394-6.
34. Kuo HP, Rohde JA, Tokuyama K, Barnes PJ, Rogers DF. Capsaicin and sensory neuropeptide stimulation of goblet cell secretion in guinea-pig trachea. J Physiol (Lond) 1990; 431:629-41.
35. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241:1218-21.
36. Martling CR. Sensory nerves containing tachykinins and CGRP in the lower airways. Functional implications for bronchoconstriction, vasodilatation and protein extravasation. Acta Physiol Scand 1987; 563 (Suppl.):1-57.
37. Piotrowski W, Foreman JC. Some effects of calcitonin gene-related peptide in human skin and on histamine release. Br J Dermatol 1986; 114:37-46.
38. Springer J, Geppetti P, Fischer A, Groneberg DA. Calcitonin gene-related peptide as inflammatory mediator. Pulm Pharmacol Ther 2003; 16:121-30.
39. Nieber K, Baumgarten C, Witzel A et al. The possible role of substance P in the allergic reaction, based on two different provocation models. Int Arch Allergy Appl Immunol 1991; 94:334-8.
40. Juliusson S, Pipkorn U, Karlsson G, Enerback L. Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms. J Allergy Clin Immunol 1992; 90:898-909.
41. Igarashi Y, Goldrich MS, Kaliner MA et al. Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal subjects. J Allergy Clin Immunol 1995; 95:716-25.
42. Takeda N, Kalubi B, Abe Y et al. Neurogenic inflammation in nasal allergy: histochemical and pharmacological studies in guinea pigs. A review. Acta Otolaryngol 1993; 501 (Suppl.): 21-4.
43. Groneberg DA, Welker P, Fischer TC et al. Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis. J Allergy Clin Immunol 2003; 111:1099-105.
44. Baraniuk JN, Castellino S, Lundgren JD et al. Neuropeptide Y (NPY) in human nasal mucosa. Am J Respir Cell Mol Biol 1990; 3:165-73.
45. Pernow J. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control. Acta Physiol Scand 1988; 568 (Suppl.):1-56.
46. Baraniuk JN, Silver PB, Kaliner MA, Barnes PJ. Neuropeptide Y is a vasoconstrictor in human nasal mucosa. J Appl Physiol 1992; 73:1867-72.
47. Groneberg DA, Heppt W, Welker P et al. Aspirin-sensitive rhinitis-associated changes in upper airway innervation. Eur Respir J 2003; 22:986-91.
48. Carr MJ, Hunter DD, Undem BJ. Neurotrophins and asthma. Curr Opin Pulm Med 2001; 7:1-7.
49. Fischer A, McGregor GP, Saria A, Philippin B, Kummer W. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation. J Clin Invest 1996; 98:2284-91.